AzTrials
AzTrials

HemiparesisNCT07077837

Effect of Incorporating Perceptual Learning Into Plantar Hardness Discrimination on the Risk of Falling and Muscle Torque in Patients With Hemiplegia

A study testing Study Group in people with Hemiparesis and Balance, run by Al-Zaytoonah University of Jordan at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hemiplegia, a common stroke sequela, significantly impairs motor function, leading to balance issues and increased fall risk. Traditional rehabilitation methods often fall short in fully restoring function. This study explores Perceptual Learning's role in enhancing balance training outcomes. Read more about this study

Who is it for?
Ages 45 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Hemiparesis, Balance
What is being tested?
Study Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteEgypt
Study dates
7 Oct 2025to 24 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • age from 45 to 65 years old
  • both Sex
  • the duration of illness more than six months
  • post stroke hemiplegia
  • spasticity ranged from (1:1+) according to Modified Ashworth Scale
  • Body mass index (BMI) ranged from 18.5 to 29.9 Kg/m2.

Who cannot join

  • 1) stroke occurred less than 3 months ago (2) Patients with severe cognitive or psychiatric impairment aphasia who could not understand the instructions given to him by physical therapist or unable to perform the task (3) any other orthopedic disorders or neurologic diseases.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo

Other trials in Egypt

About this study

Hemiplegia, a common stroke sequela, significantly impairs motor function, leading to balance issues and increased fall risk. Traditional rehabilitation methods often fall short in fully restoring function. This study explores Perceptual Learning's role in enhancing balance training outcomes.

Conditions
Hemiparesis, Balance
Being tested
Study Group, Control
Keywords
planter pressure, hemiplegia, balance
Medical subject headings
Paresis, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Study GroupOther

    received perceptual learning using plantar hardness discrimination and conventional treatment

  • ControlOther

    received conventional treatment (balance exercise functional care training

Study groups in NCT07077837
Study groupRoleWhat they receive
study groupExperimentalreceived perceptual learning using plantar hardness discrimination and conventional treatmen
Receives: Other: Study Group
control groupActive comparatorreceived conventional treatment (balance exercise functional care training)
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. risk of fall

    The Biodex Balance System is advice to measure different parameter of body balance, posture stability and risk of falling

    Measured: 4 weeks

Secondary outcomes (2)
  1. muscle torque

    Isokinetic devices are used in assessments to evaluate muscle strength and function by measuring resistance at a constant speed. These devices, often called isokinetic dynamometers, are particularly helpful in identifying muscle weaknesses

    Measured: 4 weeks

  2. Functional independent measures scale

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2025
  2. Study start7 Oct 2025
  3. Primary completion15 Nov 2025
  4. Study completion24 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07077837
Sponsor's protocol ID
hemiplegia
Status last verified
Nov 2025
First submitted
3 Jul 2025
Last updated
2 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Study Group in people with Hemiparesis and Balance, run by Al-Zaytoonah University of Jordan at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

risk of fall (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in